Release Date: 16/01/12 19:27 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 25.91KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress